Leaderboards/Psoriasis: Treatment and Pathogenesis

Psoriasis: Treatment and Pathogenesis

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Antony Raharja
Whipps Cross University Hospital
2
Zhijie Ruan
Tongji University
3
Duohang Bi
Medical Protective
4
Cong-cong He
First Hospital of China Medical University
5
Dandan Yang
Broad Institute
6
Ipsita Subudhi
NYU Langone Health
7
Xue-Er Zhang
Chengdu University of Traditional Chinese Medicine
8
Jelena Petković-Dabić
University of Banja Luka
9
Luc Francis
King's College London
10
Kellen Cavagnero
University of San Diego

Papers

1
Publication in Nature Communications (2024) [91 citations, W4391338926]
Nature Communications|2024
91 cit.
2
Publication in Immunity (2024) [83 citations, W4398146780]
Immunity|2024
83 cit.
3
Microbiome: Role in Inflammatory Skin Diseases
Journal of Inflammation Research|2024
82 cit.
4
Publication in Journal of Allergy and Clinical Immunology (2024) [70 citations, W4397010107]
Journal of Allergy and Clinical Immunology|2024
70 cit.
5
CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
The Journal of Experimental Medicine|2024
50 cit.
6
Publication in Cell Reports (2025) [5 citations, W4413117290]
Cell Reports|2025
5 cit.
7
Enhanced intracellular delivery of multi-responsive and size-switchable nanoparticles via microneedles for targeted psoriasis therapy
Journal of Controlled Release|2025
4 cit.
8
Publication in Journal of Allergy and Clinical Immunology (2025) [3 citations, W4411329309]
Journal of Allergy and Clinical Immunology|2025
3 cit.
9
Surgically induced scleritis after pars plana vitrectomy or scleral buckling surgery: a 12-year audit
Eye|2025
2 cit.
10
Disease context dictates the cellular targets of IL-17 in inflammatory skin disease
bioRxiv (Cold Spring Harbor Laboratory)|2026
1 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Cristina M. Tato
Chan Zuckerberg Initiative (United States)
2
Vidhya Hariharan
American Academy of Dermatology
3
Zhan Su
Chengdu University of Traditional Chinese Medicine
4
Abby Jacobson
Bausch Health (United States)
5
Svitlana Tatulych
Pfizer (United States)
6
Stefania Madonna
Istituto Dermopatico dell'Immacolata
7
Osamu Nemoto
Kishokai Medical Corporation
8
Wu Zhu
Central South University
9
Todd Fox
Novartis (Switzerland)
10
Alexander Egeberg
University of Copenhagen

Papers

1
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
Seminars in Arthritis and Rheumatism|2022
87 cit.
2
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
The Lancet Regional Health - Europe|2023
41 cit.
3
Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort
BMJ Open|2022
26 cit.
4
RAS-activated PI3K/AKT signaling sustains cellular senescence via P53/P21 axis in experimental models of psoriasis
Journal of Dermatological Science|2024
26 cit.
5
Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort study
Journal of the European Academy of Dermatology and Venereology|2022
25 cit.
6
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level
JAMA Dermatology|2022
22 cit.
7
Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
JAAD International|2023
22 cit.
8
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
British Journal of Dermatology|2022
21 cit.
9
Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity
Journal of the European Academy of Dermatology and Venereology|2022
21 cit.
10
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)
British Journal of Dermatology|2023
21 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Dan R. Littman
Howard Hughes Medical Institute
2
Chen Dong
East China University of Technology
3
James G. Krueger
Rockefeller University
4
Vijay K. Kuchroo
Broad Institute
5
Casey T. Weaver
University of Alabama at Birmingham
6
C.E.M. Griffiths
King's College London
7
Joel M. Gelfand
University of Pennsylvania
8
John J. O’Shea
National Institute of Arthritis and Musculoskeletal and Skin Diseases
9
Brigitta Stockinger
The Francis Crick Institute
10
Ghazala Khan
University of Wales

Papers

1
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
Nature|2006
6.9k cit.
2
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
Clinical and Experimental Dermatology|1994
5.5k cit.
3
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
Cell|2006
5.1k cit.
4
Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
Nature Immunology|2005
4.7k cit.
5
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Cell|2009
4.5k cit.
6
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Nature Immunology|2005
4.2k cit.
7
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
Immunity|2006
3.6k cit.
8
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Immunity|2003
3.3k cit.
9
Transforming growth factor-β induces development of the TH17 lineage
Nature|2006
3k cit.
10
Analysis of Fractalkine Receptor CX<sub>3</sub>CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion
Molecular and Cellular Biology|2000
2.6k cit.

Reagents for Psoriasis: Treatment and Pathogenesis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-Thr-Pro-Arg Motif [pTPR] MultiMab® Rabbit Monoclonal Antibody mix

Cited in 7 papers
#8142$194,446
View Evidence →
Cell Signaling TechnologyEvidence 64

Tris Buffered Saline with Tween 20 (TBST-10X)

Cited in 7 papers
#9997$92
View Evidence →
Cell Signaling TechnologyEvidence 64

LIN28A (D84C11) Rabbit Monoclonal Antibody

Cited in 7 papers
#3695$161,384
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Toll-like Receptor 9 (D2C9) Rabbit Monoclonal Antibody

Cited in 20 papers
#5845$152,351
View Evidence →
Cell Signaling TechnologyEvidence 66

CD14 (D7A2T) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 14 papers
#33676$465
View Evidence →
Cell Signaling Technology

GRB10 Antibody

Cited in 8 papers
#3702$317
View Evidence →